Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells

J Hepatol. 2007 Jan;46(1):124-33. doi: 10.1016/j.jhep.2006.07.027. Epub 2006 Sep 22.

Abstract

Background/aims: Collagen accumulation in liver fibrosis is due in part to decreased expression of matrix metalloproteinase (MMP)-1 relative to TIMP-1. LX-2 hepatic stellate cells produce increased amounts of collagen and tissue inhibitor of metalloproteinase (TIMP)-1 in response to leptin. The effect of leptin on MMP-1 production has not been reported.

Methods: LX-2 cells were treated with leptin with or without inhibitors. We determined: phosphorylation of Janus kinase (JAK) 1 and -2, signal transducer and activator of transcription (STAT)3 and -5, extracellular signal-regulated kinase (ERK)1/2 and p38 by Western blot; H2O2 concentration by a colorimetric method; MMP-1 mRNA levels and stability by Northern blot; MMP-1 promoter activity as well as pro-MMP-1 by ELISA; and active MMP-1 by fluorescence.

Results: LX-2 cells constitutively expressed the MMP-1 gene and leptin repressed the basal level of MMP-1 mRNA and its promoter activity. The repression was mediated by JAK/STAT pathway in synergism with JAK-mediated H2O2-dependent ERK1/2 and p38 pathways. ERK1/2 inhibited MMP-1 promoter activity, whereas p38 decreased the message stability, contributing to mRNA down-regulation. Inhibition of MMP-1 gene diminished secreted pro-MMP-1 and active MMP-1.

Conclusions: Leptin represses MMP-1 gene expression via the synergistic actions of the JAK/STAT pathway and JAK-mediated H2O2-dependent ERK1/2 and p38 pathways.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Base Sequence
  • Catalase / metabolism
  • Cell Line
  • Down-Regulation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Hepatocytes / drug effects*
  • Hepatocytes / metabolism*
  • Humans
  • Hydrogen Peroxide / metabolism
  • Imidazoles / pharmacology
  • Janus Kinases / antagonists & inhibitors
  • Leptin / pharmacology*
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / metabolism
  • MAP Kinase Signaling System / drug effects
  • Matrix Metalloproteinase 1 / biosynthesis
  • Matrix Metalloproteinase 1 / genetics*
  • Models, Biological
  • Oligodeoxyribonucleotides, Antisense / genetics
  • Pyridines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • STAT3 Transcription Factor / antagonists & inhibitors
  • STAT3 Transcription Factor / genetics
  • STAT5 Transcription Factor / antagonists & inhibitors
  • STAT5 Transcription Factor / genetics
  • Tyrphostins / pharmacology

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Leptin
  • Oligodeoxyribonucleotides, Antisense
  • Pyridines
  • RNA, Messenger
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • STAT5 Transcription Factor
  • Tyrphostins
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • Hydrogen Peroxide
  • Catalase
  • Janus Kinases
  • Matrix Metalloproteinase 1
  • SB 203580